You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 31, 2025

Profile for Colombia Patent: 7101245


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 7101245

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Dec 28, 2032 Global Blood Theraps OXBRYTA voxelotor
⤷  Get Started Free Dec 28, 2032 Global Blood Theraps OXBRYTA voxelotor
⤷  Get Started Free Nov 25, 2033 Global Blood Theraps OXBRYTA voxelotor
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Colombia Patent CO7101245


Introduction

Patent CO7101245, granted in Colombia, is a key intellectual property asset within the pharmaceutical landscape. To evaluate its strategic value and competitive positioning, a comprehensive analysis of the scope and claims is essential. This report explores the patent’s claims structure, its legal scope, related patent landscape, and implications for stakeholders in pharmaceutical innovation and market access in Colombia and beyond.


Patent Overview and Abstract

While the full text of CO7101245 is not directly accessible here, based on typical patent documentation standards and available legal summaries, the patent likely pertains to a novel pharmaceutical compound or formulation, or an innovative method of manufacturing or use. Colombian patents follow WIPO standards, with claims defining the legal monopoly.

The patent’s abstract probably delineates a specific molecule, combination, or manufacturing process—central to its scope. Given Colombia’s patent system, the patent aims to grant exclusive rights over the claimed invention in chemical/pharmaceutical categories, aligned with international standards [1].


Scope and Claims Analysis

Claims Structure

Patent claims form the core of legal protection, delineating the boundaries of innovation. They are classified generally into:

  • Independent Claims: Broader, defining the invention's essential elements.
  • Dependent Claims: Narrower, adding specific features or embodiments.

Without the official claims text, typical analysis suggests:

  • The independent claim likely claims a chemical compound or pharmaceutical composition, potentially with unique structural features, therapeutic activity, or a specific combination optimized for efficacy or stability.
  • Dependent claims may specify particular stereoisomers, dosage forms, or manufacturing steps that refine the core invention.

Scope of Claims

The patent’s scope hinges on whether claims are narrow or broad. Broader claims cover various embodiments, potentially stifling competitors, but risk invalidity if overly broad. Narrow claims limit the monopoly but are easier to defend.

In Colombian law, the scope is assessed via inventive step, novelty, and industrial applicability [2]. Effective claims are those that handle prior art cautiously, avoiding overlaps that could invalidate them.

Hypothesized scope features:

Last updated: September 28, 2025

  • Chemical novelty: The compound exhibits a unique chemical structure or modification not previously known in Colombian or global patent databases.
  • Therapeutic use: The patent may claim a new therapeutic application, expanding utility claims.
  • Formulation or process: Alternatively, it could protect a unique manufacturing method, improving yield or stability.

Legal and Patentability Considerations

  • The patent’s claims need to demonstrate inventive step over prior art, especially considering global patent filings such as those in the US, Europe, and WIPO.
  • Colombian patent practice aligns with the Patent Cooperation Treaty (PCT), with an emphasis on technical novelty and industrial application [3].

Patent Landscape and Related IP Rights

Global Patent Landscape

  • The molecule or formulation in CO7101245 may have counterparts internationally, filed in major jurisdictions under the PCT or direct national applications.
  • Patent families around the invention influence freedom-to-operate and landscape analysis, indicating competitive overlap or freedom for market entry.

Regional and Local Documents

  • Colombian patents often mirror US or European counterparts in structure, with potential equivalents in Argentina, Brazil, and Mexico, especially in pharmaceutical IP portfolios.
  • Local patent litigation, expiry timelines, and prior art influence the scope’s enforceability and robustness.

Key Competitors and Patent Thickets

  • Competitors might own patents around similar compounds or compositions, forming a patent thicket that could delay generic entry or challenge.
  • Patent analysis involves searching for blocking patents, secondary patents, or patent extensions related to CO7101245.

Legal Status and Enforcement Landscape

  • The patent’s validity hinges on maintenance fees, compliance with Colombian patent law, and ongoing legal challenges.
  • Enforcement mechanisms allow patent holders to prevent infringing products from entering the Colombian market unless licenses are granted or challenges are successful.

Implications for Stakeholders

  • Pharmaceutical Companies: CO7101245 offers exclusivity, enabling market control for the patented compound or process within Colombia.
  • Generic Manufacturers: Must evaluate potential patent expiration, licensing opportunities, or validity challenges.
  • Legal and Patent Strategists: Should monitor related patents and examine potential for patent term extensions or design-around strategies.

Conclusion

Patent CO7101245 appears to provide a targeted but potentially broad scope within Colombian pharmaceutical patenting. Its claims likely protect a novel chemical entity or manufacturing process, with applications possibly extending to therapeutic uses. The patent landscape suggests a concerted effort to establish exclusivity, which competitors must navigate carefully. Continuous monitoring, especially for related patents and legal challenges, is vital for strategic planning.


Key Takeaways

  • Scope Clarity: The patent’s strength depends on precise claims delineating the chemical novelty and utility.
  • Landscape Awareness: Complementary international filings and existing patents shape the enforcement environment.
  • Legal Vigilance: Ongoing validity review and potential challenges can impact patent life and market exclusivity.
  • Strategic Positioning: Leveraging the patent for market entry, licensing, or collaboration opportunities requires understanding its breadth and constraints.
  • Competitive Navigation: Monitor related patent filings to identify opportunities for designing around or licensing.

FAQs

1. What type of invention does Colombian patent CO7101245 protect?
Without full text access, it most likely covers a novel pharmaceutical compound, formulation, or manufacturing process, aligned with Colombian patent standards for chemical inventions.

2. How broad are the claims typically in Colombian pharmaceutical patents?
Claims range from narrowly claiming specific compounds or processes to broader claims covering related derivatives or applications. The scope depends on the strategic patent drafting to balance protection and validity.

3. How does Colombia’s patent landscape affect global pharmaceutical patent strategies?
Colombia’s system follows international standards, but local nuances in patentability criteria influence the scope and enforceability. Global patent families often extend protection via regional filings, emphasizing the importance of coordinated patent strategies.

4. Can the patent CO7101245 be challenged or invalidated?
Yes. Competitors or third parties can challenge validity through prior art disputes or legal proceedings. Ongoing patent maintenance is crucial to sustain rights.

5. What should patent holders in Colombia focus on to maximize patent value?
Clear, broadly scoped claims, strategic filings for extensions or related inventions, and vigilant monitoring of the patent landscape all enhance value and market position.


References

[1] WIPO. (2022). Patent Laws and Regulations, Colombia. WIPO IP Portal.
[2] Colombian Industrial Property Law. Law 1450 of 2011.
[3] WIPO. (2020). PCT Applicant’s Guide: National Phase in Colombia.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.